(Q33895461)

29 July 2017

1 reference

title

Placebo effect in randomized, controlled maintenance studies of patients with bipolar disorder (English)

1 reference

29 July 2017

0 references

1 reference

1 reference

5

McElroy SL

1 reference

29 July 2017

1

Keck PE Jr

1 reference

29 July 2017

Welge JA

2

1 reference

29 July 2017

Strakowski SM

series ordinal

3

1 reference

29 July 2017

Arnold LM

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

29 July 2017

published in

Biological Psychiatry

1 reference

29 July 2017

volume

47

1 reference

29 July 2017

issue

8

1 reference

29 July 2017

page(s)

756-761

1 reference

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Prophylactic lithium in affective disorders. Controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Diagnostic Criteria for Use in Psychiatric Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Prophylactic lithium in recurrent affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Recurrence in affective disorder. I. Case register study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Use of placebos in clinical trials involving children and adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

The Use of Lithium in Affective Disorders, III: A Double-Blind Study of Prophylaxis in Bipolar Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Twelve-month outcome after a first hospitalization for affective psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

First-episode mania in late life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

A controlled evaluation of lithium prophylaxis in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900309-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00309-1

1 reference

29 July 2017

1 reference